After multivariable adjustment, including adiposity measures (BMI and ɛ(WC|BMI + height)), we observed a statistically significant association of baseline FABP‐4 concentrations with the risk of CRC‐specific and all‐cause mortality (Table 2). This evidence concerns the gene FABP4 and colorectal carcinoma.